Literature DB >> 16552763

Stiff man-like syndrome and generalized myokymia in spinocerebellar ataxia type 3.

José Berciano1, Jon Infante, Antonio García, Carmen de Pablos, Guillermo Amer, José Miguel Polo, Victor Volpini, Onofre Combarros.   

Abstract

We describe the novel association of spinocerebellar ataxia type 3/Machado-Joseph disease (SCA3/MJD) phenotype combining classical clinical presentation and semeiology mimicking stiff man syndrome (SMS). The studied pedigree comprises seven affected members in three generations. Their clinical picture consisted of cerebellar ataxia, pyramidal signs, facial myokymia, and ophthalmoplegia. The proband was a 39-year-old man in whom such a clinical picture, 5 years after onset at age 29, evolved to severe SMS and widespread myokymia. Electrophysiological study revealed continuous muscle activity in proximal limb muscles. Molecular study demonstrated the MJD gene mutation in all four examined patients with 73 to 76 CAG repeats in the expanded allele. We conclude that an excess of motor unit activity including stiff man-like syndrome and widespread myokymia may be an integral part of the SCA3 clinical spectrum. (c) 2006 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16552763     DOI: 10.1002/mds.20865

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  2 in total

1.  Familial dyskinesia and facial myokymia (FDFM): Follow-up of a large family and linkage to chromosome 3p21-3q21.

Authors:  Wendy H Raskind; Mark Matsushita; Beate Peter; Jeffrey Biberston; John Wolff; Hillary Lipe; Ruben Burbank; Thomas D Bird
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-06-05       Impact factor: 3.568

Review 2.  Movement Disorders in Autosomal Dominant Cerebellar Ataxias: A Systematic Review.

Authors:  Malco Rossi; Santiago Perez-Lloret; Daniel Cerquetti; Marcelo Merello
Journal:  Mov Disord Clin Pract       Date:  2014-06-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.